Literature DB >> 1690929

Excitatory amino acids and Parkinson's disease.

W J Schmidt, M Bubser, W Hauber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690929     DOI: 10.1016/0166-2236(90)90066-j

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


× No keyword cloud information.
  9 in total

1.  A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease.

Authors:  J E Nash; J M Brotchie
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Neuroprotective potential of ionotropic glutamate receptor antagonists.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Neurotox Res       Date:  2002-03       Impact factor: 3.911

3.  Werner J. Schmidt (1950-2007). Pushing the boundary of neuroscience: a true academician and a complete gentleman.

Authors:  Trevor Archer; Richard J Beninger
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

4.  Anticataleptic potencies of glutamate-antagonists.

Authors:  W J Schmidt; B Zadow; B D Kretschmer; W Hauber
Journal:  Amino Acids       Date:  1991-06       Impact factor: 3.520

5.  Behavioral characterization of GLT1 (+/-) mice as a model of mild glutamatergic hyperfunction.

Authors:  Anna Kiryk; Tomomi Aida; Kohichi Tanaka; Pradeep Banerjee; Grzegorz M Wilczynski; Ksenia Meyza; Ewelina Knapska; Robert K Filipkowski; Leszek Kaczmarek; Wojciech Danysz
Journal:  Neurotox Res       Date:  2008-01       Impact factor: 3.911

6.  Paraquat as an Environmental Risk Factor in Parkinson's Disease Accelerates Age-Related Degeneration Via Rapid Influx of Extracellular Zn2+ into Nigral Dopaminergic Neurons.

Authors:  Haruna Tamano; Ryusuke Nishio; Hiroki Morioka; Ryo Furuhata; Yuuma Komata; Atsushi Takeda
Journal:  Mol Neurobiol       Date:  2019-05-22       Impact factor: 5.590

7.  The adenosine receptor antagonist theophylline induces a monoamine-dependent increase of the anticataleptic effects of NMDA receptor antagonists.

Authors:  W Hauber; M Münkle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

8.  Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism.

Authors:  Nathalie Breysse; Christelle Baunez; Will Spooren; Fabrizio Gasparini; Marianne Amalric
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

9.  Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.

Authors:  M S Starr; B S Starr
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.